These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 28893843)

  • 1. Timing of Angiography and Outcomes in High-Risk Patients With Non-ST-Segment-Elevation Myocardial Infarction Managed Invasively: Insights From the TAO Trial (Treatment of Acute Coronary Syndrome With Otamixaban).
    Deharo P; Ducrocq G; Bode C; Cohen M; Cuisset T; Mehta SR; Pollack C; Wiviott SD; Elbez Y; Sabatine MS; Steg PG
    Circulation; 2017 Nov; 136(20):1895-1907. PubMed ID: 28893843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulation with otamixaban and ischemic events in non-ST-segment elevation acute coronary syndromes: the TAO randomized clinical trial.
    Steg PG; Mehta SR; Pollack CV; Bode C; Cohen M; French WJ; Hoekstra J; Rao SV; Ruzyllo W; Ruiz-Nodar JM; Sabaté M; Widimsky P; Kiss RG; Navarro Estrada JL; Hod H; Kerkar P; Guneri S; Sezer M; Ruda M; Nicolau JC; Cavallini C; Ebrahim I; Petrov I; Kim JH; Jeong MH; Ramos Lopez GA; Laanmets P; Kovar F; Gaudin C; Fanouillere KC; Minini P; Hoffman EB; Moryusef A; Wiviott SD; Sabatine MS;
    JAMA; 2013 Sep; 310(11):1145-55. PubMed ID: 23995608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence, clinical determinants and prognostic implications of coronary procedural complications of percutaneous coronary intervention in non-ST-segment elevation myocardial infarction: Insights from the contemporary multinational TAO trial.
    Abtan J; Wiviott SD; Sorbets E; Popovic B; Elbez Y; Mehta SR; Sabatine MS; Bode C; Pollack CV; Cohen M; Moccetti T; Laanmets P; Faxon D; Okreglicki A; Ducrocq G; Steg PG;
    Arch Cardiovasc Dis; 2021 Mar; 114(3):187-196. PubMed ID: 33518473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated Clotting Time to Guide Heparin Dosing in Non-ST-Segment-Elevation Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention and Treated With IIb/IIIa Inhibitors: Impact on Ischemic and Bleeding Outcomes: Insights From the TAO Trial.
    Dillinger JG; Ducrocq G; Elbez Y; Cohen M; Bode C; Pollack C; Nicolau JC; Henry P; Kedev S; Wiviott SD; Sabatine MS; Mehta SR; Steg PG
    Circ Cardiovasc Interv; 2018 Jun; 11(6):e006084. PubMed ID: 29895599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and rationale of the treatment of acute coronary syndromes with otamixaban trial: a double-blind triple-dummy 2-stage randomized trial comparing otamixaban to unfractionated heparin and eptifibatide in non-ST-segment elevation acute coronary syndromes with a planned early invasive strategy.
    Steg PG; Mehta SR; Pollack CV; Bode C; Gaudin C; Fanouillere K; Moryusef A; Wiviott SD; Sabatine MS
    Am Heart J; 2012 Dec; 164(6):817-24.e13. PubMed ID: 23194481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editor's Choice-Acute versus subacute angiography in patients with non-ST-elevation myocardial infarction - the NONSTEMI trial phase I.
    Stengaard C; Sørensen JT; Rasmussen MB; Søndergaard HM; Dodt KK; Niemann T; Frost L; Jensen T; Hansen TM; Riddervold IS; Rasmussen CH; Giebner M; Aarøe J; Maeng M; Christiansen EH; Kristensen SD; Bøtker HE; Terkelsen CJ
    Eur Heart J Acute Cardiovasc Care; 2017 Sep; 6(6):490-499. PubMed ID: 27154526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex Differences in Ischemic and Bleeding Outcomes in Patients With Non-ST-Segment-Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Insights From the TAO Trial.
    Dillinger JG; Ducrocq G; Elbez Y; Cohen M; Bode C; Pollack C; Petrauskiene B; Henry P; Dorobantu M; French WJ; Wiviott SD; Sabatine MS; Mehta SR; Steg PG
    Circ Cardiovasc Interv; 2021 Jan; 14(1):e009759. PubMed ID: 33430604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trial.
    Sabatine MS; Antman EM; Widimsky P; Ebrahim IO; Kiss RG; Saaiman A; Polasek R; Contant CF; McCabe CH; Braunwald E
    Lancet; 2009 Sep; 374(9692):787-95. PubMed ID: 19717184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editor's Choice-Medically managed patients with non-ST-elevation acute myocardial infarction have heterogeneous outcomes, based on performance of angiography and extent of coronary artery disease.
    Feldman L; Steg PG; Amsallem M; Puymirat E; Sorbets E; Elbaz M; Ritz B; Hueber A; Cattan S; Piot C; Ferrières J; Simon T; Danchin N;
    Eur Heart J Acute Cardiovasc Care; 2017 Apr; 6(3):262-271. PubMed ID: 26758543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphine and Cardiovascular Outcomes Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Undergoing Coronary Angiography.
    Furtado RHM; Nicolau JC; Guo J; Im K; White JA; Sabatine MS; Newby LK; Giugliano RP
    J Am Coll Cardiol; 2020 Jan; 75(3):289-300. PubMed ID: 31976867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timing of in-hospital coronary artery bypass graft surgery for non-ST-segment elevation myocardial infarction patients results from the National Cardiovascular Data Registry ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines).
    Parikh SV; de Lemos JA; Jessen ME; Brilakis ES; Ohman EM; Chen AY; Wang TY; Peterson ED; Roe MT; Holper EM;
    JACC Cardiovasc Interv; 2010 Apr; 3(4):419-27. PubMed ID: 20398870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-Year Impact of Immediate Invasive Strategy in Patients With Non-ST-Segment Elevation Myocardial Infarction (from the RIDDLE-NSTEMI Study).
    Milasinovic D; Milosevic A; Vasiljevic-Pokrajcic Z; Marinkovic J; Vukcevic V; Stefanovic B; Asanin M; Stankovic S; Ivanovic B; Stankovic G
    Am J Cardiol; 2018 Jul; 122(1):54-60. PubMed ID: 29705375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Acute Versus Subacute Coronary Angiography in Patients With NON-ST-Elevation Myocardial Infarction (from the NONSTEMI Trial).
    Rasmussen MB; Stengaard C; Sørensen JT; Riddervold IS; Søndergaard HM; Niemann T; Dodt KK; Frost L; Jensen T; Raungaard B; Hansen TM; Giebner M; Rasmussen CH; Bøtker HE; Kristensen SD; Maeng M; Christiansen EH; Terkelsen CJ
    Am J Cardiol; 2019 Sep; 124(6):825-832. PubMed ID: 31324357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timing of angiography with a routine invasive strategy and long-term outcomes in non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II (Fragmin and Fast Revascularization During Instability in Coronary Artery Disease), ICTUS (Invasive Versus Conservative Treatment in Unstable Coronary Syndromes), and RITA-3 (Intervention Versus Conservative Treatment Strategy in Patients With Unstable Angina or Non-ST Elevation Myocardial Infarction) Trials.
    Damman P; van Geloven N; Wallentin L; Lagerqvist B; Fox KA; Clayton T; Pocock SJ; Hirsch A; Windhausen F; Tijssen JG; de Winter RJ
    JACC Cardiovasc Interv; 2012 Feb; 5(2):191-9. PubMed ID: 22361604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early versus delayed, provisional eptifibatide in acute coronary syndromes.
    Giugliano RP; White JA; Bode C; Armstrong PW; Montalescot G; Lewis BS; van 't Hof A; Berdan LG; Lee KL; Strony JT; Hildemann S; Veltri E; Van de Werf F; Braunwald E; Harrington RA; Califf RM; Newby LK;
    N Engl J Med; 2009 May; 360(21):2176-90. PubMed ID: 19332455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trial.
    Tricoci P; Lokhnygina Y; Berdan LG; Steinhubl SR; Gulba DC; White HD; Kleiman NS; Aylward PE; Langer A; Califf RM; Ferguson JJ; Antman EM; Newby LK; Harrington RA; Goodman SG; Mahaffey KW
    Circulation; 2007 Dec; 116(23):2669-77. PubMed ID: 18025532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and outcomes of patients with type 2 myocardial infarction: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial.
    Guimarães PO; Leonardi S; Huang Z; Wallentin L; de Werf FV; Aylward PE; Held C; Harrington RA; Moliterno DJ; Armstrong PW; White HD; Alexander KP; Lopes RD; Mahaffey KW; Tricoci P
    Am Heart J; 2018 Feb; 196():28-35. PubMed ID: 29421012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic benefit from an early invasive strategy in patients with non-ST elevation acute coronary syndrome (NSTEACS): evaluation of the new risk stratification in the NSTEACS European guidelines.
    Martinón-Martínez J; Álvarez Álvarez B; González Ferrero T; García-Rodeja Arias F; Otero García Ó; Cacho Antonio C; Abou Jokh Casas C; Zuazola P; Cordero A; Escribano D; Cid Alvarez B; Iglesias Álvarez D; Agra Bermejo R; Rigueiro Veloso P; García Acuña JM; Gude Sampedro F; González Juanatey JR
    Clin Res Cardiol; 2021 Sep; 110(9):1464-1472. PubMed ID: 33687519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upstream clopidogrel use and the efficacy and safety of early eptifibatide treatment in patients with acute coronary syndrome: an analysis from the Early Glycoprotein IIb/IIIa Inhibition in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome (EARLY ACS) trial.
    Wang TY; White JA; Tricoci P; Giugliano RP; Zeymer U; Harrington RA; Montalescot G; James SK; Van de Werf F; Armstrong PW; Braunwald E; Califf RM; Newby LK
    Circulation; 2011 Feb; 123(7):722-30. PubMed ID: 21300952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin monotherapy or bivalirudin during percutaneous coronary intervention in patients with non-ST-segment-elevation acute coronary syndromes or stable ischemic heart disease: results from the Evaluation of Drug-Eluting Stents and Ischemic Events registry.
    Bangalore S; Pencina MJ; Kleiman NS; Cohen DJ
    Circ Cardiovasc Interv; 2014 Jun; 7(3):365-73. PubMed ID: 24736878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.